FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Ericsson A, Richard DJ, Wilker E, Lancia JDR, Fessler S, Troccolo P, Zheng X, Toms A, Dinsmore C, Yao L, Kuypers FA, Larkin S, Marcotte D, Fulzele K, Ribadeneira M, Guichard SM, Marshall G.
Ericsson A, et al. Among authors: toms a.
Exp Hematol. 2024 Nov 14:104673. doi: 10.1016/j.exphem.2024.104673. Online ahead of print.
Exp Hematol. 2024.
PMID: 39549740
Free article.